By Elena Vardon

GSK said it raised 885.6 million pounds ($1.08 billion) from the sale of some of its shares in Haleon, reducing its stake in the consumer-healthcare business to around 7.4%.

The British pharmaceutical giant said on Friday that it placed around 270 million Haleon shares at 328 pence each. This represents a 2.45% discount to Haleon's closing price on Thursday of 336.25 pence.

U.S. pharma giant Pfizer holds a 32% stake in Haleon, which was spun out of GSK and Pfizer's consumer healthcare business.

Write to Elena Vardon at elena.vardon@wsj.com

(END) Dow Jones Newswires

October 06, 2023 02:37 ET (06:37 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos GSK.
GSK (NYSE:GSK)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos GSK.